During the past 12 months, Euro-Med Laboratories Philippines's average EPS without NRIGrowth Rate was 40.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 11.00% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was -9.10% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was -1.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Euro-Med Laboratories Philippines's highest 3-Year average EPS without NRI Growth Rate was 17.00% per year. The lowest was -28.80% per year. And the median was -2.65% per year.
Euro-Med Laboratories Philippines EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Euro-Med Laboratories Philippines's EPS (Diluted)
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines's PE Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's PE Ratio distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱0.07
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Euro-Med Laboratories Philippines EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of Euro-Med Laboratories Philippines's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Euro-Med Laboratories Philippines (PHS:EURO) Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small volume parenterals and other solutions. The company also manufactures sterile water for the injection, and other solutions such as ophthalmic, inhalation, irrigation and dialysis. It operates through the following segments: The Manufacturing pharmaceutical segment involves the manufacturing of pharmaceutical products. The Health and other care Service segment operates a dialysis center. Development and operation of quick-service restaurant segment include operations of the quick-service restaurant, catering, food production and other related services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PHS:EURO has been successfully added to your 